ACT EU: Call for nominations to Multi-stakeholder Platform Advisory Group (2027-2029)

The Accelerating Clinical Trials in the EU (ACT EU) initiative has launched a call for nominations to renew the composition of its Multi-stakeholder Platform Advisory Group (MSP AG) for the 2027-2029 mandate. The MSP AG supports dialogue between regulators and stakeholders on matters related to clinical trials and contributes to the continuous improvement of the EU clinical trials environment. Organisations representing European patients and consumers, healthcare professionals, academia, industry and research funders are invited to submit nominations for one representative and one alternate. In addition, based on the topics to be discussed during each MSP AG meeting, experts from other stakeholder groups may join on an ad hoc basis.